Notably, in December last year, Deep Intelligent Pharma had just announced a US$50 million Series D financing. In less than two months, the company has raised over US$100 million in total.

Claude Sonnet 4.6 beats Opus in agentic tasks, adds 1 million context, and excels in finance and automation, all at one-fifth ...

Research findings are available online in the journal Nature Metabolism. The original story “ Sweating may naturally suppress ...

This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS ...

The Biological Computing Co. (TBC), the company redefining computing for the post-silicon AI era, today launched a new class of compute that integrates living neurons with modern AI, becoming the ...

“It was the first proof point,” said Pomeraniec. “We could actually take information from the real world, translate it into a ...

Apophenia is the mind’s tendency to find meaning in randomness. It shapes creativity, emotion, and misunderstanding, ...

Mutations in the ‘C9orf72’ gene cause progressive neurodegenerative diseases, namely Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).

A team led by Northwestern University and Shirley Ryan AbilityLab scientists have developed a new technology that can eavesdrop on the hidden electrical dialogues unfolding inside miniature, lab-grown ...

Battery tech startup e-TRNL Energy has bagged ₹27.4 Cr (around $3 Mn) in its seed funding round led by IAN Alpha Fund ...

Dare we say, it’s about time?! Apple is reportedly preparing its most ambitious MacBook Pro redesign in years, breaking a decade-long stance by adding touchscreen support alongs ...